A total of N = 12 children and adolescents with T1D treated by continuous subcutaneous insulin infusion participated in a clinical research study conducted at the Wellcome Trust Clinical Research Facility, Addenbrooke's Hospital, University of Cambridge, UK 24. The gene discussed is INS; the disease is type 1 diabetes mellitus.